ES2045475T3 - Rna del genoma del virus de la hepatitis no-a, no-b, cdna y proteina del antigeno del virus. - Google Patents
Rna del genoma del virus de la hepatitis no-a, no-b, cdna y proteina del antigeno del virus.Info
- Publication number
- ES2045475T3 ES2045475T3 ES89313362T ES89313362T ES2045475T3 ES 2045475 T3 ES2045475 T3 ES 2045475T3 ES 89313362 T ES89313362 T ES 89313362T ES 89313362 T ES89313362 T ES 89313362T ES 2045475 T3 ES2045475 T3 ES 2045475T3
- Authority
- ES
- Spain
- Prior art keywords
- hepatitis
- cdna
- viruses
- rna
- genoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000700605 Viruses Species 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 208000006454 hepatitis Diseases 0.000 title abstract 2
- 231100000283 hepatitis Toxicity 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
EL GENOMERO DE ARN DEL VIRUS DE HEPATITIS NO-A Y NO-B, ES DESCRITO A LO LARGO DE LA PROTEINA ANTIGEN DE VIRUS Y EL CDNA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63322547A JPH02167081A (ja) | 1988-12-21 | 1988-12-21 | 非A非B型肝炎ウイルスゲノムRNA、cDNAおよびウイルス抗原蛋白質 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2045475T3 true ES2045475T3 (es) | 1994-01-16 |
Family
ID=18144889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89313362T Expired - Lifetime ES2045475T3 (es) | 1988-12-21 | 1989-12-20 | Rna del genoma del virus de la hepatitis no-a, no-b, cdna y proteina del antigeno del virus. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5077193A (es) |
EP (1) | EP0377303B1 (es) |
JP (1) | JPH02167081A (es) |
AT (1) | ATE81357T1 (es) |
CA (1) | CA2005950C (es) |
DE (1) | DE68903165T2 (es) |
DK (1) | DK648689A (es) |
ES (1) | ES2045475T3 (es) |
GR (1) | GR3006171T3 (es) |
IE (1) | IE63306B1 (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698390A (en) * | 1987-11-18 | 1997-12-16 | Chiron Corporation | Hepatitis C immunoassays |
US6861212B1 (en) | 1987-11-18 | 2005-03-01 | Chiron Corporation | NANBV diagnostics and vaccines |
US5350671A (en) * | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
US6171782B1 (en) | 1987-11-18 | 2001-01-09 | Chiron Corporation | Antibody compositions to HCV and uses thereof |
US5714596A (en) * | 1987-11-18 | 1998-02-03 | Chiron Corporation | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
US5712088A (en) * | 1987-11-18 | 1998-01-27 | Chiron Corporation | Methods for detecting Hepatitis C virus using polynucleotides specific for same |
US5789559A (en) * | 1988-06-17 | 1998-08-04 | Genelabs Technologies, Inc. | DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent |
US5824649A (en) * | 1988-06-17 | 1998-10-20 | Genelabs Technologies, Inc. | DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof |
US5191064A (en) * | 1988-09-30 | 1993-03-02 | The Research Foundation For Microbial Diseases (Osaka University) | Non-a, non-b hepatitis virus antigen peptide |
US6027729A (en) * | 1989-04-20 | 2000-02-22 | Chiron Corporation | NANBV Diagnostics and vaccines |
US5372928A (en) * | 1989-09-15 | 1994-12-13 | Chiron Corporation | Hepatitis C virus isolates |
US7166287B1 (en) | 1989-12-18 | 2007-01-23 | Glaxo Wellcome Inc. | Viral agent |
NO905438L (no) | 1989-12-18 | 1991-06-19 | Wellcome Found | Virusmiddel. |
US5747339A (en) | 1990-06-25 | 1998-05-05 | Research Foundation For Microbial Diseases Of Osaka | Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide |
US7863008B2 (en) | 1990-08-25 | 2011-01-04 | Bioprocess Pty Ltd. | Method for detecting NANBV associated seroconversion |
ATE346302T1 (de) * | 1990-08-25 | 2006-12-15 | Bioprocess Pty Ltd | Nicht-a, nicht-b hepatitis virus antigen, und diagnostische verfahren. |
US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
CA2065690A1 (en) * | 1991-04-10 | 1992-10-11 | Hiroaki Okamoto | Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides |
WO1994018217A1 (en) * | 1993-02-03 | 1994-08-18 | Abbott Laboratories | Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
US5859230A (en) * | 1992-07-30 | 1999-01-12 | Genelabs Technologies, Inc. | Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof |
ATE179459T1 (de) * | 1992-11-27 | 1999-05-15 | Innogenetics Nv | Verfahren zur typisierung von hcv-isolaten |
US7258977B1 (en) | 1992-11-27 | 2007-08-21 | Innogenetics N.V. | Process for typing of HCV isolates |
US5824507A (en) * | 1994-05-20 | 1998-10-20 | Genelabs Technologies, Inc. | Hepatitis G virus and molecular cloning thereof |
US5874563A (en) * | 1994-05-20 | 1999-02-23 | Genelabs Technologies, Inc. | Hepatitis G virus and molecular cloning thereof |
US7235394B1 (en) | 1995-08-29 | 2007-06-26 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US6127116A (en) | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US7049428B1 (en) * | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
US7338759B1 (en) | 1997-03-04 | 2008-03-04 | Washington University | HCV variants |
US6586584B2 (en) | 2001-01-29 | 2003-07-01 | Becton, Dickinson And Company | Sequences and methods for detection of Hepatitis C virus |
US7196183B2 (en) * | 2001-08-31 | 2007-03-27 | Innogenetics N.V. | Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
US8124747B2 (en) * | 2003-08-29 | 2012-02-28 | Innogenetics | HCV clade and prototype sequences thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3744242A1 (de) * | 1987-02-20 | 1989-07-06 | Seelig Renate | Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff) |
CN1049686C (zh) * | 1987-11-18 | 2000-02-23 | 希龙股份有限公司 | 非a和非b肝炎病毒的诊断及疫苗 |
IL91371A0 (en) * | 1988-08-24 | 1990-04-29 | Us Commerce | Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood |
-
1988
- 1988-12-21 JP JP63322547A patent/JPH02167081A/ja active Pending
-
1989
- 1989-12-19 IE IE408389A patent/IE63306B1/en not_active IP Right Cessation
- 1989-12-19 DK DK648689A patent/DK648689A/da not_active Application Discontinuation
- 1989-12-19 CA CA002005950A patent/CA2005950C/en not_active Expired - Fee Related
- 1989-12-20 EP EP89313362A patent/EP0377303B1/en not_active Expired - Lifetime
- 1989-12-20 DE DE8989313362T patent/DE68903165T2/de not_active Expired - Lifetime
- 1989-12-20 ES ES89313362T patent/ES2045475T3/es not_active Expired - Lifetime
- 1989-12-20 AT AT89313362T patent/ATE81357T1/de not_active IP Right Cessation
-
1990
- 1990-06-19 US US07/540,604 patent/US5077193A/en not_active Expired - Fee Related
-
1992
- 1992-11-05 GR GR920402492T patent/GR3006171T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IE63306B1 (en) | 1995-04-05 |
IE894083L (en) | 1990-06-21 |
GR3006171T3 (es) | 1993-06-21 |
EP0377303B1 (en) | 1992-10-07 |
DK648689D0 (da) | 1989-12-19 |
CA2005950C (en) | 1996-06-11 |
US5077193A (en) | 1991-12-31 |
CA2005950A1 (en) | 1990-06-21 |
DE68903165D1 (de) | 1992-11-12 |
JPH02167081A (ja) | 1990-06-27 |
DE68903165T2 (de) | 1993-03-11 |
EP0377303A1 (en) | 1990-07-11 |
ATE81357T1 (de) | 1992-10-15 |
DK648689A (da) | 1990-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2045475T3 (es) | Rna del genoma del virus de la hepatitis no-a, no-b, cdna y proteina del antigeno del virus. | |
ES2078255T3 (es) | Regiones inmunogenas en la proteina e-7 del papilomavirus humano tipo 16. | |
CL2009002139A1 (es) | Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral. | |
ATA902590A (de) | Rekombinantes pockenvirus | |
ES2061708T3 (es) | Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus. | |
ATE88900T1 (de) | Konjugate von interferon alpha mit immunglobulinen. | |
DE69016956T2 (de) | Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor. | |
PT725824E (pt) | Epitopos de celulas t humanas imunodominantes do virus da hepatite c | |
PT83434B (pt) | Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida | |
ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
FR2620459B1 (fr) | Virus recombinant de la vaccine | |
BR9202024A (pt) | Virus de apivox recombinante,cultura de celulas eucariotica infectadas por um virus de avipox,vacina,sequencia de transferencia e plasmideo | |
DE69101683D1 (de) | Rekombinantes Mareks-Krankheitsvirus. | |
DE69433007D1 (de) | Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus | |
DE3872754D1 (de) | Nachweis von antikoerpern humaner immundefizienz-viren. | |
TW377373B (en) | Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease | |
IT1249684B (it) | Epitopi della proteina env del virus dell'epatite c. | |
ES2181502T3 (es) | Tratamiento de la infeccion de hepatitis b con timosina alfa 1 y lamivudina. | |
DE69232650T2 (de) | Vakzine gegen katzenleukämievirus | |
FI923020A (fi) | Inte a inte b-sekvenser. | |
DE69011122T2 (de) | Rubella-e1 und c peptide. | |
DE494825T1 (de) | Synthetische peptide von hepatitis-b-virus-hbc-antigen. | |
IT1270941B (it) | Peptidi di hcv e loro usi. | |
SU1702657A1 (ru) | Пептид, обладающий защитным действием против вируса ящура штамма a | |
FR2655855B1 (fr) | Protection genetique d'animaux contre l'infection par le virus leucemogene bovin, et provirus et virus recombinant derive de ce virus. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 377303 Country of ref document: ES |